Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 494.76% | 257.84% | 136.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 494.76% | 257.84% | 136.16% |
| Cost of Revenue | -- | -- | 345.94% | 235.56% | 209.04% |
| Gross Profit | -- | -- | 1,658.96% | 341.19% | -40.50% |
| SG&A Expenses | -- | -- | 64.01% | 112.96% | 352.83% |
| Depreciation & Amortization | -- | -- | -52.58% | -81.89% | -69.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 73.22% | 98.33% | 251.69% |
| Operating Income | -- | -- | -38.53% | -77.23% | -282.08% |
| Income Before Tax | -- | -- | -7.47% | -12.24% | -416.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -7.47% | -12.24% | -416.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 596.17% | 360.19% | 230.23% |
| Net Income | -- | -- | -3.28% | -10.66% | -418.02% |
| EBIT | -- | -- | -38.53% | -77.23% | -282.08% |
| EBITDA | -- | -- | -47.65% | -105.42% | -380.49% |
| EPS Basic | -- | -- | -14.28% | -35.61% | -543.33% |
| Normalized Basic EPS | -- | -- | -68.56% | -159.75% | -491.82% |
| EPS Diluted | -- | -- | -14.28% | -35.61% | -543.33% |
| Normalized Diluted EPS | -- | -- | -68.56% | -159.75% | -491.82% |
| Average Basic Shares Outstanding | -- | -- | -8.74% | -21.65% | -22.97% |
| Average Diluted Shares Outstanding | -- | -- | -8.74% | -21.65% | -22.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
